Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials.

Liew AY, Eikelboom JW, Connolly SJ, O' Donnell M, Hart RG.

Int J Stroke. 2014 Feb;9(2):199-206. doi: 10.1111/ijs.12036. Epub 2013 Mar 19. Review.

PMID:
23506160
2.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Review.

PMID:
22161375
3.

Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.

Rengo G, Pagano G, Squizzato A, Moja L, Femminella GD, de Lucia C, Komici K, Parisi V, Savarese G, Ferrara N, Perrone-Filardi P, Leosco D.

PLoS One. 2013;8(1):e52952. doi: 10.1371/journal.pone.0052952. Epub 2013 Jan 2. Review.

4.

Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.

Kumar G, Goyal MK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1279-87. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.015. Epub 2012 Nov 20. Review.

PMID:
23182364
5.

Antiplatelet therapy and anticoagulation in patients with hypertension.

Griffin G.

Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.

6.

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Hart RG, Benavente O, McBride R, Pearce LA.

Ann Intern Med. 1999 Oct 5;131(7):492-501.

7.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC.

Cochrane Database Syst Rev. 2004;(3):CD003186. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD003186.

PMID:
15266473
9.
10.

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

Massie BM, Krol WF, Ammon SE, Armstrong PW, Cleland JG, Collins JF, Ezekowitz M, Jafri SM, O'Connor CM, Packer M, Schulman KA, Teo K, Warren S.

J Card Fail. 2004 Apr;10(2):101-12.

PMID:
15101020
11.

Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

Lee M, Saver JL, Hong KS, Wu HC, Ovbiagele B.

Circ Heart Fail. 2013 Mar;6(2):287-92. doi: 10.1161/CIRCHEARTFAILURE.112.971697. Epub 2012 Dec 21. Review.

12.

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Hart RG, Pearce LA, Aguilar MI.

Ann Intern Med. 2007 Jun 19;146(12):857-67.

PMID:
17577005
13.

Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.

De Schryver EL, Algra A, van Gijn J.

Cochrane Database Syst Rev. 2003;(1):CD001820. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD001820.

PMID:
12535415
14.

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.

Lip GY, Gibbs CR.

Cochrane Database Syst Rev. 2001;(4):CD003333. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD003333.

PMID:
11687189
15.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
16.

Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.

Algra A, De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001342. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD001342.

PMID:
16855967
17.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
18.

[A meta-analysis on efficacy of anti-platelet agents and anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation].

Tu RH, Zhong GQ, Zeng ZY, Wu WF, He Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Mar;39(3):262-7. Chinese.

PMID:
21609534
19.

WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001938. Review.

PMID:
17636690
20.

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

Cochrane Database Syst Rev. 2001;(1):CD001938. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001938.

PMID:
11279741

Supplemental Content

Support Center